AZD1390 suppressed NF‐κB signaling pathway through restricting ubiquitylation and sumoylation of NEMO, which alleviated ischemic brain injury in experimental stroke and attenuated the activation of microglia and neuroinflammation. The gene discussed is NFKB1; the disease is stroke disorder.